These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28633491)

  • 1. Optimization of inactivated H5N9 highly pathogenic avian influenza vaccine and inactivated Salmonella enterica serovar Typhimurium vaccine with antigen dose and prime-boost regimen in domestic ducks.
    Yuk SS; To EO; Kwon JH; Noh JY; Hong WT; Jeong JH; Gwon GB; Song CS
    Poult Sci; 2017 Sep; 96(9):3079-3085. PubMed ID: 28633491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response in domestic ducks following intradermal delivery of inactivated vaccine against H5N1 highly pathogenic avian influenza virus adjuvanted with oligodeoxynucleotides containing CpG motifs.
    Yuk SS; Lee DH; Park JK; To EO; Kwon JH; Noh JY; Gomis S; Song CS
    Poult Sci; 2015 Aug; 94(8):1836-42. PubMed ID: 26069254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased efficacy of inactivated vaccine candidates prepared with Salmonella enterica serovar Typhimurium strains of predominant genotypes in ducks.
    Youn SY; Kwon YK; Song CS; Lee HJ; Jeong OM; Choi BK; Jung SC; Kang MS
    Poult Sci; 2016 Aug; 95(8):1764-73. PubMed ID: 26994209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI.
    Steensels M; Bublot M; Van Borm S; De Vriese J; Lambrecht B; Richard-Mazet A; Chanavat-Bizzini S; Duboeuf M; Le Gros FX; van den Berg T
    Vaccine; 2009 Jan; 27(5):646-54. PubMed ID: 19056442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prime-boost vaccination with attenuated Salmonella Typhimurium ΔznuABC and inactivated Salmonella Choleraesuis is protective against Salmonella Choleraesuis challenge infection in piglets.
    Alborali GL; Ruggeri J; Pesciaroli M; Martinelli N; Chirullo B; Ammendola S; Battistoni A; Ossiprandi MC; Corradi A; Pasquali P
    BMC Vet Res; 2017 Sep; 13(1):284. PubMed ID: 28893256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge.
    Steensels M; Van Borm S; Lambrecht B; De Vriese J; Le Gros FX; Bublot M; van den Berg T
    Avian Dis; 2007 Mar; 51(1 Suppl):325-31. PubMed ID: 17494576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
    Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE
    Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pekin and Muscovy ducks respond differently to vaccination with a H5N1 highly pathogenic avian influenza (HPAI) commercial inactivated vaccine.
    Cagle C; To TL; Nguyen T; Wasilenko J; Adams SC; Cardona CJ; Spackman E; Suarez DL; Pantin-Jackwood MJ
    Vaccine; 2011 Sep; 29(38):6549-57. PubMed ID: 21771626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Two Licensed Avian Influenza H5 Vaccines Against Challenge with a 2015 U.S. H5N2 clade 2.3.4.4 Highly Pathogenic Avian Influenza Virus in Domestic Ducks.
    Pantin-Jackwood MJ; DeJesus E; Costa-Hurtado M; Smith D; Chrzastek K; Kapczynski DR; Suarez DL
    Avian Dis; 2019 Mar; 63(1):90-96. PubMed ID: 31251524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
    Kilany WH; Safwat M; Mohammed SM; Salim A; Fasina FO; Fasanmi OG; Shalaby AG; Dauphin G; Hassan MK; Lubroth J; Jobre YM
    PLoS One; 2016; 11(6):e0156747. PubMed ID: 27304069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
    Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
    Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection afforded by avian influenza vaccination programmes consisting of a novel RNA particle and an inactivated avian influenza vaccine against a highly pathogenic avian influenza virus challenge in layer chickens up to 18 weeks post-vaccination.
    Ladman BS; Gelb J; Sauble LA; Murphy MV; Spackman E
    Avian Pathol; 2019 Aug; 48(4):371-381. PubMed ID: 30961360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks.
    Prel A; Le Gall-Reculé G; Jestin V
    Avian Pathol; 2008 Oct; 37(5):513-20. PubMed ID: 18798027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus.
    Niqueux E; Guionie O; Amelot M; Jestin V
    Vaccine; 2013 Aug; 31(38):4121-8. PubMed ID: 23845804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.
    Sun X; Belser JA; Pulit-Penaloza JA; Creager HM; Guo Z; Jefferson SN; Liu F; York IA; Stevens J; Maines TR; Jernigan DB; Katz JM; Levine MZ; Tumpey TM
    Virology; 2017 Aug; 508():164-169. PubMed ID: 28554058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of live attenuated Salmonella vaccines in newly hatched duckings.
    Tang T; Gao Q; Barrow P; Wang M; Cheng A; Jia R; Zhu D; Chen S; Liu M; Sun K; Yang Q; Chen X
    Vaccine; 2015 Oct; 33(42):5564-5571. PubMed ID: 26382600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmonella DIVA vaccine reduces disease, colonization and shedding due to virulent S. Typhimurium infection in swine.
    Bearson BL; Bearson SMD; Brunelle BW; Bayles DO; Lee IS; Kich JD
    J Med Microbiol; 2017 May; 66(5):651-661. PubMed ID: 28516860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salmonella typhimurium grown in iron-rich media, inactivated with ferric chloride and adjuvanted with homologous bacterial DNA is potent and efficacious vaccine in mice.
    Kumar D; Singh A
    Vaccine; 2005 Dec; 23(48-49):5590-8. PubMed ID: 16098639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a live attenuated Salmonella enterica serovar Typhimurium vaccine on farrow-to-finish pig farms.
    De Ridder L; Maes D; Dewulf J; Butaye P; Pasmans F; Boyen F; Haesebrouck F; Van der Stede Y
    Vet J; 2014 Nov; 202(2):303-8. PubMed ID: 25278382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of live attenuated Salmonella enterica serovar Typhimurium expressing chicken interferon-α alleviates clinical signs caused by respiratory infection with avian influenza virus H9N2.
    Rahman MM; Uyangaa E; Han YW; Kim SB; Kim JH; Choi JY; Yoo DJ; Hong JT; Han SB; Kim B; Kim K; Eo SK
    Vet Microbiol; 2011 Dec; 154(1-2):140-51. PubMed ID: 21764226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.